Peter Lam
About Peter Lam
Peter Lam is the Global Medical Oncology Director - Thoracic Cancers and SCCHN Lead at Bristol Myers Squibb, with extensive experience in oncology medical affairs and clinical development.
Title
Peter Lam holds the position of Global Medical Oncology Director - Thoracic Cancers and SCCHN Lead at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Peter Lam is currently employed at Bristol Myers Squibb, where he serves as the Global Medical Oncology Director, focusing on Thoracic Cancers and Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Previous Roles at Bristol Myers Squibb
Peter Lam has held multiple roles at Bristol Myers Squibb. In 2022, he worked as the Global Medical Oncology Director, Medical Markets Lead - Early & Transition Assets for nine months in New Jersey, United States. He also served as the Global Medical Oncology Director, Medical Markets Lead - GI and GU Cancers (Interim) for five months in 2022.
Experience at MSD
Peter Lam worked at MSD as the Regional Medical Director for Global Oncology Medical Affairs in Japan, China & Asia Pacific (JCAP) from 2019 to 2021, stationed in Singapore.
Early Career and Education
Peter Lam began his career with roles at Eisai Canada, Costco Wholesale Canada, Shoppers Drug Mart, and Amgen. He also served as a research assistant at McGill University and McMaster University. Peter holds a Doctor of Pharmacy (Pharm.D.) from the University of Toronto and a Bachelor of Science (B.Sc.) in Biology & Pharmacology Co-op with Summa Cum Laude honors from McMaster University.
Expertise in Oncology
Peter Lam is known for his analytical and strategic thinking within clinical development. He has a proven track record working on oncology products, managing both their pre-launch and mature phases in large market and start-up environments. His expertise spans thoracic cancers and squamous cell carcinoma of the head and neck.